-
Protein A/G Magnetic Beads: Practical Workflow
2026-09-11
Protein A/G Magnetic Beads support Fc-mediated antibody capture for purification, immunoprecipitation, co-IP, and Ch-IP from complex biological samples. This guide separates product specifications from workflow recommendations and notes limitations for assays requiring validated recovery, diagnostic use, or antibodies without an accessible IgG Fc region.
-
STT3B Inhibition Protects Against α-Amanitin Toxicity
2026-09-11
Wang et al. combined a genome-wide CRISPR-Cas9 screen, computational drug repurposing, and validation in cells, liver organoids, and mice to identify STT3B as a host determinant of α-amanitin toxicity. Their results nominate indocyanine green as a candidate STT3B inhibitor that can reduce toxin-associated injury, while also defining important limits for translating cellular protection into treatment of amatoxin poisoning.
-
Polyphenol-Armored Nanogene for Aged Osteoarthritis
2026-09-10
This Advanced Science study combines an adhesive, lubricating hydrogel with polyphenol-armored nanoparticles carrying miR-140-5p to address several barriers in aged osteoarthritis. The platform is designed to retain cargo in the joint, protect RNA from senescence-associated degradation, improve intracellular delivery, and reduce oxidative stress while restoring chondrocyte homeostasis.
-
Diclofenac in Reliable Cell Assays
2026-09-10
Learn how Diclofenac (SKU B3505) can support controlled viability, proliferation, cytotoxicity, and cyclooxygenase inhibition workflows. This scenario-based guide connects formulation, vehicle controls, organoid models, data interpretation, and supplier selection to practical laboratory decisions.
-
Adiponectin, TLR4, and Cognitive Deficits in Aged Rats
2026-09-09
This reference study examined whether adiponectin protects aged rats from splenectomy-associated cognitive impairment and tested the TLR4/MyD88/NF-κB axis as a mechanistic link between peripheral surgical trauma, hippocampal inflammation, and oxidative injury. Adiponectin improved Morris water maze performance and reduced inflammatory, oxidative-stress, and apoptosis-related markers, but the preclinical findings require validation in broader surgical and clinical models.
-
Ginkgetin, Laptm5, and Sepsis-Induced Lung Injury
2026-09-09
A 2026 Phytomedicine study links ginkgetin protection against sepsis-induced acute lung injury to suppression of Laptm5 ubiquitination, enhanced autophagy, and TBK1 degradation in macrophages. The work provides a mechanistic framework for studying macrophage inflammatory regulation and for designing complementary gene-expression validation workflows.
-
RHEB Neddylation, mTORC1, and Liver Tumorigenesis
2026-09-08
The reference study identifies RHEB as a non-cullin substrate of the UBE2F–SAG neddylation machinery and shows that modification at K169 enhances RHEB lysosomal localization, GTP binding, and mTORC1 activation. Genetic, cellular, animal, and patient-correlation data connect this pathway to hepatic steatosis, hepatocellular carcinoma, and survival, while also defining important limits for translation.
-
Sulfo-NHS-SS-Biotin: Mapping Dynamic Cell Surfaces
2026-09-08
A thought-leadership guide to using reversible amine-reactive biotinylation to interrogate cell-surface protein domains, validate glycoRNA–RNA-binding protein biology, and build more decision-ready translational assays.
-
Mitoxantrone HCl: DNA Topoisomerase II Workflows
2026-09-07
Mitoxantrone HCl supports DNA-damage, apoptosis, viability, and receptor-degradation studies when dose, solvent, and orthogonal readouts are controlled. Its emerging ERα interface mechanism also enables assays that distinguish canonical topoisomerase II effects from allosteric receptor disruption.
-
Rotavirus Infection Suppresses Nrf2 Antioxidant Defense
2026-09-07
The reference study shows that rotavirus infection produces a biphasic Nrf2 response: an early, redox-sensitive increase is followed by pronounced loss of Nrf2, nuclear depletion, and suppression of antioxidant transcription. Its layered perturbation strategy indicates that late Nrf2 depletion is not explained by canonical Keap1 turnover alone and instead involves proteasome-associated, K48-linked ubiquitination.
-
Bovine Insulin in ER-Stress Cell Models
2026-09-05
Bovine insulin is more than a routine culture supplement: it can be a carefully controlled metabolic variable in hepatocyte ER-stress and HMGB1 secretion assays. This article connects insulin handling, assay design, and the QRICH1–SIRT6–HMGB1 axis without overstating evidence from disease models.
-
Epidermal Growth Factor: Assay Workflows
2026-09-04
Translate recombinant human EGF into reproducible proliferation, migration, and signaling assays with defined dosing, timing, and controls. Learn why EGF-driven migration should be separated from EMT and invasion, and how APExBIO product specifications support practical cell-culture workflows.
-
TCAIM Controls OGDH in Mitochondrial Metabolism
2026-09-04
Wang et al. identify TCAIM as a mitochondrial DNAJC co-chaperone that selectively binds native OGDH and promotes its reduction through HSPA9 and LONP1. The study establishes a post-translational mechanism linking mitochondrial proteostasis to OGDH complex activity, carbohydrate catabolism, and broader metabolic regulation.
-
SLC2A5 Fructose Metabolism in Primary CNS Lymphoma
2026-09-03
This study uses single-cell RNA and B-cell receptor profiling to show that glucose-poor, hypoxic conditions in primary central nervous system lymphoma redirect tumor and macrophage biology toward SLC2A5-mediated fructose metabolism. Genetic and pharmacological SLC2A5 inhibition suppressed lymphoma growth in functional models, identifying a tumor–microenvironment metabolic vulnerability with potential translational relevance.
-
IGFBP2–THBS1 Axis in GH-Driven Bone Growth
2026-09-03
The reference study identifies an IGFBP2–THBS1 regulatory axis that helps explain how growth hormone promotes chondrocyte proliferation and hypertrophic differentiation in idiopathic short stature. By combining patient plasma proteomic analysis with human chondrocyte loss- and gain-of-function experiments, it connects GH exposure to enhanced IGF-1 signaling while defining important limits for clinical translation.